Advertisement

Ethicon Biosurgery wins FDA clearance for its Evarrest fibrin sealant patch, which is designed to aid in stopping unexpected and uncontrollable bleeding during surgery.

Ethicon logo

The FDA cleared Ethicon Biosurgery's Evarrest fibrin sealant patch for use during surgery to help stop problematic bleeding, which can raise a patient's mortality rate to 20% in some cases, the company said.

The Evarrest features a coating of biologics, which can initiate a fibrin clot and help form a flexible patch that adheres to a wound, according to the press release.

Advertisement
Advertisement